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Mexico City Metropolitan Area children chronically exposed to high concentrations of
air pollutants exhibit an early brain imbalance in genes involved in oxidative stress,
inflammation, innate and adaptive immune responses along with accumulation of
misfolded proteins observed in the early stages of Alzheimer and Parkinson’s diseases.
A complex modulation of serum cytokines and chemokines influences children’s brain
structural and gray/white matter volumetric responses to air pollution. The search for
biomarkers associating systemic and CNS inflammation to brain growth and cognitive
deficits in the short term and neurodegeneration in the long-term is our principal aim.
We explored and compared a profile of cytokines, chemokines (Multiplexing LASER
Bead Technology) and Cellular prion protein (PrPC) in normal cerebro-spinal-fluid (CSF) of
urban children with high vs. low air pollution exposures. PrPC and macrophage inhibitory
factor (MIF) were also measured in serum. Samples from 139 children ages 11.91 ± 4.2
years were measured. Highly exposed children exhibited significant increases in CSF MIF
(p = 0.002), IL6 (p = 0.006), IL1ra (p = 0.014), IL-2 (p = 0.04), and PrPC (p = 0.039) vs.
controls. MIF serum concentrations were higher in exposed children (p = 0.009). Our
results suggest CSF as a MIF, IL6, IL1Ra, IL-2, and PrPC compartment that can possibly
differentiate air pollution exposures in children. MIF, a key neuro-immune mediator, is
a potential biomarker bridge to identify children with CNS inflammation. Fine tuning of
immune-to-brain communication is crucial to neural networks appropriate functioning, thus
the short and long term effects of systemic inflammation and dysregulated neural immune
responses are of deep concern for millions of exposed children. Defining the linkage and
the health consequences of the brain / immune system interactions in the developing
brain chronically exposed to air pollutants ought to be of pressing importance for public
health.
Keywords: Alzheimer, air pollution, children, innate immunity, neurodegeneration, neuroinflammation, particulate
matter, prion cellular protein
INTRODUCTION
Air pollution is a significant health problem in megacities around
the world (Molina and Molina, 2004; Chen and Kan, 2008;
Bloom, 2011). In the first 50 years of this century (Bloom, 2011),
the projected world population will have a further increase of
2–4.5 billion making the issue of deteriorating environments and
their health impact critical.
Mexico City Metropolitan Area (MCMA) children with no
known risk factors for neurological or cognitive disorders exhibit
significant deficits in a combination of fluid and crystallized
cognition tasks vs. low air pollution exposed children (Calderón-
Garcidueñas et al., 2008a). Brain structural and volumetric
changes are seen in bothMCMA children and young animal facil-
ity dogs (Calderón-Garcidueñas et al., 2008a, 2011a, 2012a). The
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canine frontal white matter lesions are characterized by vascu-
lar sub-cortical pathology associated with neuroinflammation,
gliosis, and ultrafine particulate matter deposition (Calderón-
Garcidueñas et al., 2008a). Young MCMA residents exhibit
the neuropathological hallmarks of Alzheimer and Parkinson’s
diseases i.e., amyloid beta42 (Aβ42) plaques, tau hyperphos-
phorylation with pre-tangles and α-synuclein accumulation
(Calderón-Garcidueñas et al., 2012b).
The complex modulation of cytokines and chemokines that
influence children’s central nervous system (CNS) structural and
volumetric responses to air pollution obligate the search for
biomarkers associating systemic and CNS inflammation to brain
growth and cognitive deficits in the short term and neurodegen-
eration in the long-term (Calderón-Garcidueñas et al., 2008a,b,
2011a,b, 2012b). A good candidate biomarker, macrophage
migration inhibitory factor (MIF) is a cytokine expressed in the
CNS and involved in innate and adaptive immune responses
(Bernhagen et al., 1993; Bacher et al., 2010; Edwards et al., 2010;
Moon et al., 2012; Savaskan et al., 2012; Bucala, 2013; Cox et al.,
2013; Freiria-Oliveira et al., 2013; Turtzo et al., 2013). MIF par-
ticipates in the induction of neural stem/progenitor cells (Ohta
et al., 2012), the protection ofmice female brains after experimen-
tal stroke (Turtzo et al., 2013), the mediation of the antidepressant
action of exercise (Moon et al., 2012), and of key importance for
this work, MIF plays a key role in neuroinflammatory responses
(Savaskan et al., 2012; Cox et al., 2013).
In clinical practice and in the experimental setting, MIF has
been used as a marker of neurological worsening in progres-
sive neurodegenerative processes including multiple sclerosis and
autoimmune-mediated neuroinflammation (Hagman et al., 2011;
Cox et al., 2013), as a key neuro-immune mediator linking
depressive symptoms with inflammation and HPA dysregulation
(Edwards et al., 2010), and as a predictor of lack of response
to antidepressants (Cattaneo et al., 2013). Moreover, in the sce-
nario of air pollution and the early hallmarks of Alzheimer’s
disease (AD) in Mexico City children (Calderón-Garcidueñas
et al., 2008a, 2012a), two key issues are of utmost interest to
us: the increased concentrations of MIF in the cerebro-spinal-
fluid (CSF) of AD patients and the capacity of MIF to enhance
the ability of the tau/Aβ42 ratio to discriminate cognitively nor-
mal vs. mildly demented patients (Lee et al., 2008; Bacher et al.,
2010; Craig-Schapiro et al., 2011). In addition MIF promotes
the production of several inflammatory mediators including IL-6,
TNF α, and IFN γ (Popp et al., 2009). Given the wide spectrum
of serum and CSF responses to pathological processes includ-
ing neuroinflammation and neurodegenerative diseases such as
AD and Parkinson’s disease (PD) (Dziedzic, 2006; Helmy et al.,
2012; Yan et al., 2012; Giralt et al., 2013; Martinez et al., 2013;
Mooijaart et al., 2013; Smolen et al., 2013), we have selected a 41
cytokine/chemokine panel and MIF to explore the CSF responses
to high air pollution residency.
Cellular prion protein (PrPC) is a conserved GPI-anchored
membrane protein located on the surface of neurons, at both
pre and post-synaptic sites, with a high abundance in the hip-
pocampus, frontal cortex and stratium (Stellato et al., 2011; Ding
et al., 2013; Watt et al., 2013). The PRNP gene located in chromo-
some 20 likely plays key roles in neuronal development, synaptic
plasticity, myelin sheath maintenance, cell adhesion, CNS devel-
opment, and neuroprotection via inhibition of the mitochondrial
apoptotic pathway (Mitsios et al., 2007; Altmeppen et al., 2012;
Bradford andMabbott, 2012; Kaiser et al., 2012; Ding et al., 2013).
We are particularly interested in the critical role PrPC may play
in the integrity of the CNS under a neuroinflammatory insult,
precisely the key marker of air pollution exposure in urban chil-
dren (Bremer et al., 2010; Popko, 2010; Gourdain et al., 2012;
Scalabrino and Veber, 2012). The role of PrPC in cellular immu-
nity (Tsutsui et al., 2008), cognitive functioning (Breitling et al.,
2012), oxidative stress, and the impact of prion proteins upon the
toxic effect of environmental neurotoxic metals (Choi et al., 2007;
Oh et al., 2012) are at the core of our research.
The primary aim of this study was to measure the concen-
trations of PrPC and selected inflammatory mediators in normal
CSF from cohorts of children with high exposures to urban air
pollution vs. low pollution control children. Concurrently, we
also explored serum MIF and PrPC in clinically healthy children
representing cohorts with high and low air pollution exposures.
Our results identify CSF as a MIF, IL6, IL-1Ra, IL-2, and PrPC
compartment that differentiates children with high vs. low air
pollution exposures. The MIF increases in CSF and serum com-
partments in highly vs. low exposed children strongly suggestMIF
could be a serum biomarker bridge to identify children at risk
for brain inflammation. Short and long term effects of dysregu-
lated neural immune responses and systemic inflammation are of
pressing importance for public health.
PROCEDURE
STUDY AREAS
Children’s cohorts were selected from the MCMA and several
small cities in Mexico, characterized by clean environments with
concentrations of the six criteria air pollutants (ozone, particu-
late matter, sulfur dioxide, nitrogen oxides, carbonmonoxide and
lead) below the current US EPA standards.
PARTICIPANTS
This research was approved by the research ethics committee of
the Hospital Central Militar in Mexico City. Children gave active
assent and their parents gave written informed consent to partic-
ipation in the study. This work includes data from 139 children
74F, 65M (Meanage = 11.91 years, SD = 4.2), carefully selected
to represent comparable populations from a larger longitudi-
nal cohort research program. There were two groups of children
included in this study: Group 1 (n: 28, Meanage = 10.46 years,
SD = 4.2, low pollution 8F/6M; high pollution 6F/8M) corre-
sponded to children admitted to the hospital from either MCMA
or a low polluted city with a work up diagnosis of acute lym-
phoblastic leukemia entering a clinical protocol, which included
a spinal tap. Only cases with a normal CSF were included in
this study. None of the selected CSF samples belonged to chil-
dren with previous oncological and/or hematological treatments.
Group 2 (n: 111, 44 controls (24F/20M), 67 MCMA (33F/34M),
Meanage = 13.37 years, SD = 4.2) were clinically healthy chil-
dren from MCMA and control cities and their serum samples
were taken as part of their pediatric examination during a longi-
tudinal follow-up. Inclusion criteria for all participating children
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were: negative smoking history and environmental tobacco expo-
sure, lifelong residency in MCMA or a control city, residency
within 5 miles of the city monitoring stations, full term birth, and
unremarkable clinical histories prior to the hospital admission
(for the children CSF donors). Low and high pollution exposed
children were matched by age, gender, and socioeconomic
status.
CSF SAMPLES
Spinal tap was performed in the supine position from lum-
bar levels using a standard 22 spinal needle. CSF was collected
dripping in free air in1ml aliquot into Nalge Nunc polypropy-
lene CryoTubes. Lumbar puncture samples were collected dur-
ing non-traumatic, non-complicated procedures. CSF pleocytosis
was defined as CSF white blood cell (WBC) counts of >7 cells
per mm3. CSF samples were used for the laboratory procedures
without dilution steps.
PERIPHERAL BLOOD ANALYSIS
Blood was collected from an antecubital vein using a 21-G
needle. After centrifugation at 3000 rpm for 10min, aliquots
of 1.5ml serum were transferred to CryoTubes and sam-
ples were frozen at −20◦C and then transferred to −80◦C
and stored until further analysis. Blood samples were also
collected for a complete blood count (CBC) with differen-
tial. Serum samples were processed for Multiplexing LASER
Bead Technology (Eve Technologies, Calgary, Canada) that
included 41 cytokines and chemokines: EGF, Eotaxin, FGF-
2, Flt-3L, Fractalkine, G-CSF, GM-CSF, GRO, IFNα2, IFNγ,
IL-1α, IL-1β, IL-1ra, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8,
IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17a,
IP-10, MCP-1, MCP-3, MDC, MIP-1α, MIP-1β, PDGF-AA,
PDGF-AB/BB, RANTES, sCD40L, TGFα, TNFα, TNFβ, and
VEGF. An ELISA was done for the quantification of PrPc
in serum and CSF, BetaPrion®Human EIA (AJ RoboScreen
GmbH, Leipzig, Germany). Macrophage inhibitory factor (MIF)
was done using an ELISA procedure from R&D (Minneapolis,
MN 55413, USA). Serum samples were run without dilution
steps.
DATA ANALYSIS
First, we calculated the summary statistics (mean ± stan-
dard deviation) of all relevant variables including age, inflam-
matory mediators and PrPc results. In the 28 CSF samples,
we worked with 42 variables and established with indepen-
dent samples t-tests which variables were statistically signifi-
cant between children with high exposures to air pollutants
(Mexico City) and children residing in low pollution cities
(Controls). Spearman correlations were run between the CSF
target inflammatory mediators and PrPc. In the 111 serum
samples, we worked with 2 variables and established with inde-
pendent samples t-tests which variables were statistically signif-
icant between Mexico City and control children. Significance
was assumed at p < 0.05 and data expressed as mean val-
ues ± SD. All the statistical analyses described above were
performed on statistical software “R” (http://www.r-project.
org/).
RESULTS
CSF DATA
CSF samples were clear, colorless, with a normal opening pres-
sure, a mean WBC count of 2.1 ± 1 cells per mm3 and no
RBC. Glucose was 55.9 ± 6.7mg/100ml in controls and 54.8 ±
11.7mg/100ml in Mexico City children (p = 0.3). Table 1 shows
the results of the 42 variables included in the analysis. Six variables
Table 1 | Cerebro-spinal- fluid inflammatory mediators in Control vs.
Mexico City children (values are shown in pg/ml).
Variables Mean SD Mean SD p-value
(controls) (controls) (Mexico City) (Mexico City)
EGF 1.627 2.258 2.416 2.665 0.396
FGF2 11.972 20.495 13.294 12.858 0.838
TGFalpha 2.810 1.637 1.800 1.667 0.111
GCSF 8.389 3.668 10.602 12.673 0.526
FlT.3L 23.429 18.261 35.249 34.856 0.261
GM.CSF 4.327 2.253 2.907 1.500 0.060
Fractalkine 41.711 18.529 218.851 422.998 0.127
IFNα2 4.931 2.468 5.349 2.989 0.683
IFNγ 0.278 0.148 1.296 2.006 0.070
GRO 8.057 13.421 19.084 22.972 0.125
IL10 0.259 0.258 2.593 4.966 0.091
MCP3 3.574 3.358 3.594 5.018 0.990
IL12p40 2.030 1.131 2.526 1.564 0.335
MDC 16.996 6.852 20.768 11.320 0.285
IL12 0.473 0.939 0.637 0.516 0.571
PDGF.AA 4.351 4.690 3.210 3.483 0.467
IL13 0.516 0.229 0.477 0.255 0.673
PDGF-BB 0.963 1.494 0.635 1.301 0.535
IL15 2.920 2.491 5.237 5.317 0.144
sCD40l 2.391 5.617 1.334 1.547 0.507
IL17a 5.165 18.595 0.225 0.021 0.338
IL1ra 0.475 0.579 1.915 1.954 0.014
IL1a 0.323 0.365 0.905 1.329 0.122
IL9 0.996 1.229 0.952 0.861 0.913
IL1beta 0.231 0.043 0.642 1.389 0.272
IL2 0.218 0.042 0.530 0.532 0.040
IL3 0.220 0 0.709 1.929 0.343
IL4 2.099 0.890 2.788 1.627 0.167
IL5 0.534 0.385 3.769 12.514 0.334
IL6 1.161 0.650 21.26 38.5 0.006
IL7 0.251 0.080 0.429 0.445 0.147
IL8 17.306 26.099 26.341 37.853 0.459
IP10 207.479 492.590 296.127 519.441 0.641
MCP1 1061.199 1159.217 1521.123 2698.525 0.553
MIP1α 1.130 1.846 6.497 9.129 0.041
MIP1β 6.776 3.065 7.049 3.761 0.832
RANTES 2.121 1.720 8.667 13.963 0.093
TNFα 0.368 0.224 1.441 3.0208 0.191
TNFβ 0.471 0.843 0.987 2.384 0.442
VEGF 4.542 4.494 24.503 43.563 0.099
PrPc 4.396 3.228 8.036 5.506 0.039
MIF 66.918 24.454 329.930 264.342 0.002
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were statistically significant, including: MIF, PrPC, IL-6, IL1Ra,
IL-2, and MIP1α (this is not an effect of the number of multiple
comparisons, i.e., inflation of Type I error, because the binomial
probability that 6 comparisons out of 42 would turn out to be
significant by chance is less than 0.0001). Relevant Spearman cor-
relations between CSF PrPC and target inflammatory mediators
are seen in Table 2. We found significant correlations between
PrPC and IL-15 (p = 0.025) and RANTES (p = 0.04), MIF and
IL-6 (p < 0.000) and IL-6 with IL-15 and RANTES (p = 0.03).
SERUM DATA
MIF and PrPC results in serum are seen in Table 3. MIF was sig-
nificantly higher (p = 0.009) in Mexico City children, while PrPC
showed no differences between cohorts.
DISCUSSION
Cerebro-spinal-fluid concentrations of Macrophage migra-
tion inhibitory factor MIF, IL-6, IL-1Ra, IL-2, Macrophage
Inflammatory Protein 1-α [MIP1α,Chemokine (C-C Motif)
Ligand 3] and PrPC differentiate children with high vs. low air
pollution exposures and suggest a complex interplay of a net-
work of multipotent cytokines and normal cellular proteins with
known neuromodulatory actions participating in neuroinflam-
matory responses associated with exposures to air pollutants. Our
data also suggests that MIF in serum is a potential biomarker
bridge to identify children with CNS inflammation.
IL-6, IL-1Ra, IL-2, andMIF are important players in the patho-
genesis of neuroinflammation and the systemic inflammation
associated with chronic exposures to high concentrations of air
pollutants, while the increased CSF concentrations of PrPC could
potentially represent a neuroprotective response against oxidative
stress (Griffiths et al., 2007; Carnini et al., 2010).
IL-6 is a pleiotropic cytokine with key roles in inflamma-
tory responses and in directing T cell differentiation in adaptive
immunity. The elevation of IL-6 in the CSF of highly exposed chil-
dren and its significant correlation with other potent chemokines
and cytokines regulating and coordinating innate and adaptive
immune responses is important in the developing CNS.
IL-6 has been implicated in systemic and brain neo-
angiogenesis (Gertz et al., 2012). In traumatic brain injury the
presence of low concentrations of IL-6 [IL-6 knock-out (KO)
mice] is associated with poor behavior performance, and impacts
the expression of IL1β, another powerful pro-inflammatory
cytokine (Ley et al., 2011). Neuroprotective associations of
specific IL-6 SNP (i.e., the G-allele of the SNP rs1800795)
on hippocampal volumes (Baune et al., 2012), the protection
of midbrain dopaminergic neurons by IL-6 in the model of
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Spittau
et al., 2012), and the significant attenuation of IL-6 concen-
trations and lower gray volume in old rhesus macaques by a
caloric-restricted diet (Willette et al., 2010) support a complex
interaction between IL-6, other inflammatory mediators and pro-
tective brain responses. The role of IL-6 in long-term potentiation
(LTP) and learning is well known (Del Rey et al., 2013). The
increased expression of IL-6 is causally related to an increase in
synaptic strength since it was abrogated when LTP was interfered
by blockade of NMDA-glutamate receptors (Del Rey et al., 2013).
Detrimental effects on the other hand, are described between
high concentrations of IL-6, reduced hippocampal volumes and
major depressive disorders (Frodl et al., 2012) and in chronic
systemic inflammatory conditions with increased risk of stroke
(Drake et al., 2011). In advanced HIV infection, CSF concentra-
tions of IL-6 show elevations in patients on suppressive combina-
tion antiretroviral therapy regardless of cognitive status, implying
the persistence of intra-thecal inflammation even in the absence
of clinical manifestations (Kamat et al., 2012).
Of utmost importance for this work and the higher con-
centrations of CSF IL-6 in Mexico City children is the fact we
are seeing the hallmarks of Alzheimer i.e., hyperphosphorilated
tau and Aβ42 amyloid plaques in 44 and 51%, respectively,
of highly exposed Mexico City teens vs. 0% in low pollution
control children. In the literature involving elderly individuals,
the associations between IL-6 and dementia are controversial
(Papassotiropoulos et al., 2001; Jellinger, 2010; Helmy et al.,
2012). Galimberti et al., reported the highest CSF IL-6 concentra-
tions in AD patients with mild cognitive deterioration, suggesting
to the authors a key role of IL-6 in the initial phases of neurode-
generation (Galimberti et al., 2008). Combarros et al., suggested
that dysregulation of IL-6 in some elderly people contributes to
the development of AD (Combarros et al., 2009). Oxidative dam-
age and neuroinflammation are crucial players in neurodegener-
ative diseases (Nunomura et al., 2001, 2006, 2012a,b), and both
are present in the context of air pollution exposures (Calderón-
Garcidueñas et al., 2012a). Moreover, under experimental con-
ditions, exposures to different components of air pollutants
Table 3 | Serum MIF and PrPC in Control v Mexico City children.
Variable Controls Mexico City p-value
MIF 425.1 ± 188 711.1 ± 488.7 0.009
PrPC 1.671 ± 0.96 1.647 ± 1.465 0.21
Values are shown in pg/ml.
Table 2 | Spearman correlations in CSF target inflammatory mediators and PrPC Control v Mexico City children.
Mediator PrPC r/p-value MIF r/p-value IL-6 r/p-value IL-15 r/p-value RANTES r/p
PrPC 1000 0.307 /0.113 0.236/0.302 0.424/0.025 0.406/0.044
MIF 0.307/0.113 1000 0.773/0.000 0.233/0.232 0.236/0.256
IL-6 0.236/0.302 0.773/0.000 1000 0.467/0.033 0.476/0.034
IL-15 0.424/0.025 0.233/0.232 0.467/0.033 1000 0.692/0.000
RANTES 0.406/0.044 0.236/0.256 0.476/0.034 0.692/0.000 1000
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cause oxidative stress, neuroinflammation and neurodegenera-
tion (Calderón-Garcidueñas et al., 2003, 2008a, 2012a,b; Levesque
et al., 2011, 2013). Thus, the CSF and brain inflammatory imbal-
ance observed in highly exposed children could represent an early
physiological reaction to chronic environmental stress contribut-
ing later to the establishment of neurodegenerative processes with
childhood clinical manifestations (Calderón-Garcidueñas et al.,
2008b, 2011b, 2012b, 2013). Of critical importance are the por-
tals of entry of air pollutants in the urban setting: (i) the nasal
pathway through the olfactory, trigeminal nerves and accessory
posterolateral nerve, (ii) the red blood cells and monocytes trans-
porting ultrafine PM and then delivering the particles to distant
organs including the brain, (iii) the direct access of PM organic
and inorganic components to the systemic circulation through
the alveolar-capillary interphase, (iv) the gastrointestinal and
vagal pathways (Calderón-Garcidueñas et al., 2007; Block and
Calderón-Garcidueñas, 2009; Dhuria et al., 2010; Bleier et al.,
2012; Lucchini et al., 2012).
Thus, the association between IL-6 serum increases and
deficits in verbal memory (Grassi-Oliveira et al., 2011) obligates
us to explore the cognitive consequences of an inflammatory
imbalance and cognitive impairment in highly exposed cohorts
(Aung et al., 2011; Tsai et al., 2012; Uski et al., 2012; Wittkopp
et al., 2013).
Intrathecal inflammation in these children is counterbalanced
by the increased production of interleukin 1 receptor antago-
nist (IL-1Ra), a natural endogenous antagonist of IL-1, critical
for a variety of brain effects (Arend, 2002; Gadek-Michalska and
Bugajski, 2010; Akash et al., 2013; Peters et al., 2013). IL-1RA
exhibits low uptake in the normal brain, with rapid metabolism,
a short biological half-life (4–6 h), and excretion via the kidneys
(Cawthorne et al., 2011). IL-1Ra higher CSF concentrations in
highly exposed children, is a key observation since we have pre-
viously described a significant frontal up-regulation of IL-1β in
Mexico City children (Calderón-Garcidueñas et al., 2008a). IL-
1Ra has clear neuroprotective effects in experimental perinatal
inflammation and hypoxic-ischemic injuries (Girard et al., 2012),
reduces ischemic brain damage and inflammation in co-morbid
rats (Pradillo et al., 2012), prevents postoperative cognitive
decline and neuroinflammation in older rats (Barrientos et al.,
2012), and plays a key anti-inflammatory role in AD (Rubio-Perez
and Morillas-Ruiz, 2012). Interestingly, experimental endotox-
emia in healthy male volunteers produces significant transient
increases in IL-1Ra and decreases inmood, likely reflecting a com-
pensatory strategy or a greater social cognitive processing as a
function of sickness (Kullmann et al., 2013). We interpreted the
CSF IL-1Ra increases as a neuroprotective response in Mexico
City children.
On the other hand, the increases in CSF IL-2 are in keep-
ing with the critical role of this pro-inflammatory cytokine in
both effector T-cell development and FoxP3(+) CD4(+) Treg-cell
homeostasis (Shameli et al., 2013). Of utmost interest in the con-
text of air pollution is the role of IL-2 in regulating inflammation
in an organ-specific manner through the migration and retention
of CD4(+) T-cells (both Th1 and Th2) (Ju et al., 2012). Since IL-2
is also required for regulating the Th2 cytokine response during
T-cell activation and participates in multifactorial autoimmune
responses (Wang et al., 2009; Baine et al., 2013), the issue of
autoimmunity to CNS components warrants full investigation
in exposed children especially those with extensive white mat-
ter hyperintense lesions (Calderón-Garcidueñas et al., 2008b,
2012b).
Macrophage Inflammatory Protein 1-α [Chemokine (C-C
Motif) Ligand 3/CCR3] CSF increases in Mexico City children
relate to its well known role in inflammatory responses, angio-
genesis and tissue remodeling through binding with receptors
to other chemokines (i.e., CCR1, CCR4, CCR5) (Gaspar et al.,
2013).
MIF is a newly arrived player in the air pollution scenario, is
an active participant in innate and acquired immunity (Savaskan
et al., 2012), its association with the production of several inflam-
matory mediators including IL-6, TNF-α, and IFN-γ, and the
identification of CSF MIF as a biomarker in AD and mild
cognitive impairment patients (MCI) (Popp et al., 2009; Craig-
Schapiro et al., 2011) has a great impact in air pollution-related
brain effects.
The role of MIF as a neuro-immune mediator linking
inflammation with depressive symptoms and HPA dysregulation
(Anisman and Hayley, 2012; Savaskan et al., 2012), and its con-
comitant increases in CSF and serum makes MIF a potential
biomarker to identify children with systemic and CNS inflamma-
tion. A facet of MIF of importance for us is the potentiation with
autoimmune-mediated neuroinflammation (Cox et al., 2013).
Cox et al. demonstrated that MIF is essential for microglial acti-
vation and the production of IL-6, IL-1β, TNF-α, and inducible
NO synthase in an experimental autoimmune encephalomyeli-
tis model. Cox et al., work is important to us because the target
cytokines described in their paper are up-regulated in brain tis-
sues of highly exposed children, and the same cytokines exhibit
higher serum concentrations when compared with low pollution
exposed children (Calderón-Garcidueñas et al., 2008a,b, 2009,
2011a, 2012a,b).
The CSF increases of the normal cellular isoform of the prion
protein (PrPC) in exposed children deserve to be discussed under
three important headings:
1. The PrPC neuroprotective role related primarily to its antiox-
idant properties, its capacity as a radical scavenger, its key
role in signal transduction and cell survival, neuronal zinc
regulation, and its functional importance in the protection
against oxidative stress and metal toxicity (Brown et al.,
1997; Kuwahara et al., 1999; Viles et al., 1999; Milhavet and
Lehmann, 2002; Hu et al., 2007; Westergard et al., 2007;
Carnini et al., 2010; Martins et al., 2010; Bertuchi et al., 2012;
Alfaidy et al., 2013; Watt et al., 2013).
2. The PrPC role in animal behavior suggesting that the absence
of the prion protein could result in altered neural processing
(Massimino et al., 2013).
3. The associations of PrPC with neuropathology apart from the
conventional prion diseases (Jiménez-Huete et al., 1998; Ferrer
et al., 2001; Voigtländer et al., 2001; Checler and Vincent, 2002;
Aguzzi and Haass, 2003; Rezaie et al., 2005; Schwarze-Eicker
et al., 2005; Ramljak et al., 2008). Of interest to us are the
controversial issues in the literature linking Aβ oligomers and
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PrPC (Laurén et al., 2009; Nygaard and Strittmatter, 2009;
Gunther and Striitmatter, 2010; Kessels et al., 2010; Barry
et al., 2011; Saijo et al., 2011; Larson et al., 2012; Um et al.,
2012; Chen et al., 2013; Kudo et al., 2013; Whitehouse et al.,
2013; Younan et al., 2013). A few specific examples to make
the point: Kudo et al. showed that Prnp (-/-) mice are resis-
tant to the neurotoxic effect of oligomeric Aβ in vivo and
in vitro (Kudo et al., 2013). Chen et al. have shown PrPC over-
expression down-regulated tau protein and PrPC lacking the
Aβ oligomer binding site was incapable of rescuing the level of
tau reduction. These authors demonstrated that PrPC down-
regulated tau via Fyn pathway and the effect can be regulated
by Aβ oligomers (Chen et al., 2013). Whitehouse et al. mea-
sured PrPC in the frontal cortex of 24 sporadic AD brains vs.
24 age-matched controls and found a significant decreased of
PrPC in AD brains. Interestingly, PrPC significantly inversely
correlated with BACE1 activity, Aβ load, soluble Aβ, and insol-
uble Aβ and with the stage of disease, as indicated by Braak
tangle stage (Whitehouse et al., 2013). The authors concluded
that brain PrPC level may be important in influencing the
onset and progression of sporadic AD (Whitehouse et al.,
2013).
Why are all these papers relevant to our work? We recently
published a paper (Calderón-Garcidueñas et al., 2012a) show-
ing a 15 fold frontal down-regulation of mRNA PrPC in Mexico
City residents (18 ± 8.7 years) vs. low air pollution age matched
controls. In the same work, we showed frontal tau hyperphospho-
rylation and Aβ diffuse plaques in the exposed kids, but none
in low air pollution controls. Thus, the regional frontal PrPC
down-regulation shown by microarray analysis is of deep con-
cern given the age of the autopsy subjects (on average 8 years
older) than our CSF children in this study. PrPC might have
significant longitudinal variations in mRNA expression by brain
region (Rezaie et al., 2005; Velayos et al., 2009), age, gender, and
other factors in the setting of air pollution. Moreover, because
the CSF is produced and reabsorbed throughout the entire CSF-
Interstitial fluid (IF) functional unit (Chikly and Quaghebeur,
2013), our results highlight the need to define PrPC changes both
directly in different regions of the brain and in the CSF in low vs.
high pollution exposed children and young adults. Furthermore,
since PrPC likely plays a key protective role against sporadic AD
(Whitehouse et al., 2010; Griffiths et al., 2012) we will expect
age-related decreases in specific regional brain areas inversely
related to the development of AD hallmarks in highly exposed
individuals.
The second reason for concern is the impact of PrPC in cog-
nition. Gimbel et al. showed that AD transgenic mice with intact
PrPC expression exhibit deficits in spatial learning and memory,
while mice lacking PrPC, but containing Aβ plaque derived from
APPswe/PSen1DeltaE9 transgenes, show no detectable impair-
ment of spatial learning and memory (Gimbel et al., 2010). Thus,
deletion of PrPC expression dissociates Aβ accumulation from
behavioral impairment in AD mice, with the cognitive deficits
selectively requiring PrPC (Gimbel et al., 2010). Interestingly,
Schmidt et al. (2013) showed no association between CSF PrPC
and cognitive status in 114 AD patients, while Breitling et al.
reported in a 5 years follow-up study of 1322 elderly Germans
(aged 65+ years at baseline), an inverse association between
serum PrPc and cognitive functioning (Breitling et al., 2012). In
our study, CSF PrPC was significantly higher in exposed vs. low
pollution children, while serum PrPC concentrations showed no
differences.
The significant correlations of PrPC with RANTES and IL-
15 deserve a comment. Regulated upon Activation, Normal
T-cell Expressed and Secreted (RANTES) is a proinflamma-
tory chemokine produced by neurons and capable of upreg-
ulating neurotrophic factors and extending cell survival after
ischemic stroke (Tokami et al., 2013), while IL-15 instructs the
generation of a distinct memory T-lymphocyte subset, inter-
mediate between naive and central memory cells (Cieri et al.,
2013). These findings highlight the complex link between nor-
mal brain proteins, powerful chemokines, and immune driven
cytokines.
It has been clear for a number of years that neuroinflamma-
tion has critical implications for cognition, behavior, altered brain
growth and neurodegeneration. Brain dysbalances in inflamma-
tory mediators and alterations of essential proteins with key roles
in CNS development and neuroprotection will inevitably have
detrimental consequences for young brains. We already described
some of these consequences in Mexico City youth: differences
in white matter volumes involving right parietal and bilateral
temporal areas and cognitive deficits consistent with impairment
of the targeted lobes, olfaction deficits, auditory and vestibular
nuclei accumulating α synuclein and/or β amyloid and signifi-
cant involvement of the medial superior olive neurons, critically
involved in brainstem auditory evoked potentials. Elevation of
indices of neuroinflammation and oxidative stress, and AD and
PD associated pathology completing the grim picture (Calderón-
Garcidueñas et al., 2003, 2008a,b, 2010, 2011a,b, 2012a,b, 2013;
Calderón-Garcidueñas and Torres-Jardón, 2012).
At the core of our observations lies the complex dynamic inter-
action in different compartments of cytokines, chemokines and
brain proteins responding to the constant state of inflamma-
tion and oxidative stress resulting from unhealthy environmental
exposures. The short term consequences are having an impact
in the performance of children in school and in their violent
behavior (Calderón-Garcidueñas and Torres-Jardón, 2012), while
the longer effects are already seen in neuropathological studies
of children with accidental deaths (Calderón-Garcidueñas et al.,
2008b, 2012b, 2013). There is no doubt of the close linkage
between the brain and the immune system particularly in the
developing brain (Bilbo and Schwarz, 2012). Brisk responses are
at hand both systemically and in the brain upon endogenous
and exogenous environmental signals, however, the developing
brain is delicately sensitive to chronic stimuli and the end result
could be a pathological process with deleterious outcomes for the
individual.
LOOKING FORWARD AND LIMITATIONS
Despite controversy regarding the mechanistic pathways involved
in the CNS damage associated with exposure to air pollutants,
we agree that oxidative stress, endothelial dysfunction vascular
damage and neuroinflammation are at the core of the pathology,
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and the same factors play a key role in neurodegenerative dis-
eases (Qin et al., 2007; Rivest, 2009; Levesque et al., 2011;
Castellani and Perry, 2012; de la Torre, 2012; Nunomura et al.,
2012a,b; Calderón-Garcidueñas et al., 2013). We are looking
forward to bridging the gap between early neuroinflammation
and its neurodegenerative consequences, an issue of importance
in childhood and adolescence when cognitive performance is
critical.
There is a need for looking into the CSF early responses to
air pollution because we can connect with the knowledge avail-
able for elderly populations, i.e., the progression of Alzheimer
core biomarkers [Aβ(1-42), total tau and phosphorylated tau]
and inflammatory markers useful in the clinical practice to eval-
uate patients with mild cognitive impairment and their course to
AD. This is critical, given that implementation of early preven-
tive pathways (Castellani and Perry, 2012) in the developing brain
could ameliorate or drastically modified the pathology in later
years.
Our results are potentially limited by the fact our CSF normal
samples were taken from a population of children with a hemato-
logical workup for a neoplastic process, albeit no CNS involve-
ment, while our serum samples were from clinically healthy
children. As pediatricians we are totally aware of the ethical
issues in taking CSF samples from healthy children, so the read-
ily available normal CSF samples destined to be discarded are
a good initial source of exploratory samples. Nevertheless, the
robust CSF increase in the described inflammatory mediators in
highly exposed children warrants extensive investigations using
available normal CSF samples in Mexico and around the world.
Two issues are important here: the selection of multiplex plat-
forms and knowledge of their ability to accurately and sensitively
detect cytokines in CSF and blood (serum/plasma) (Malekzadeh
et al., 2012). The second one, the use of standardized operat-
ing procedures for the recollection of CSF samples, a key point
if we want to decrease the variability attributed to different pre-
analytical procedures between laboratories (del Campo et al.,
2012).
SUMMARY
We have quantified CSF responses for a selected panel de
inflammatory mediators and PrPC in two groups of chil-
dren with contrasting air pollution lifetime exposures. Our
results identify MIF, IL6, IL1Ra, IL-2, and PrPC as poten-
tial CSF biomarkers differentiating the high vs. low air pollu-
tion exposed children, supporting the previous evidence of an
ongoing neuroinflammatory process in Mexico City children.
Serum MIF was identified as a robust biomarker in Mexico City
children.
Fine tuning of immune-to-brain communication is crucial to
neural networks appropriate functioning, thus the short and long
term effects of systemic inflammation and dysregulated neural
immune responses are of deep concern for millions of highly
exposed children.
A large body of work on PrPc, IL-6, MIF, IL-2, and the IL-1
family already exists, thus expanding this knowledge in the sce-
nario of air pollution pediatric effects could greatly facilitate our
understanding of the downstream mechanisms of the complex
interaction of cytokines/chemokines/ PrPc immune responses in
the developing brain and the resulting short and long term brain
effects.
The role of PrPc in highly exposed children is an issue worth
investigating further as the field moves forward, since we believe
knowledge on PrPc responses in a developing brain will shed light
on neuroprotective mechanisms against the onset of Alzheimer
disease.
Although the two objectives of this study were accomplished:
(i) To evaluate the concentrations of PrPC and selected inflam-
matory mediators in normal CSF from cohorts of children with
high vs. low pollution controls and (ii) To explore serum PrPC
and MIF in clinically healthy children representing cohorts with
high and low air pollution exposures, our immediate goal will
be to assess whether the identified biomarkers will be useful
in the identification of children at higher risk for cognitive
deficits, behavioral disorders, and structural and volumetric brain
alterations.
Our ultimate goal is that following the identification of chil-
dren at the highest risk for detrimental brain effects, we pro-
tect them through multidimensional interventions yielding both
impact and reach. The prospective of our efforts is readily
apparent.
Defining the linkage and the health consequences of the
brain/immune system interactions in the developing brain chron-
ically exposed to air pollutants ought to be of pressing importance
for public health.
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